Education
About Us
Working with TipRanks
Follow Us
Futura Medical PLC (GB:FUM)
LSE:FUM
FUM Stock Chart & Stats
Day’s Range― - ―
52-Week Range8.48p - 45.56p
Previous CloseN/A
Volume13.08K
Average Volume (3M)433.36K
Market Cap
£28.07M
Enterprise Value113.29M
Total Cash (Recent Filing)£4.03M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.13
Next Earnings
Apr 09, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding303,829,680
10 Day Avg. Volume316,426
30 Day Avg. Volume433,359
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.51
Price to Cash Flow (P/CF)-4.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
140.00pPrice Target Upside1346.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Futura Medical News
PremiumCompany Announcements
Futura Medical Strengthens Board with New Appointment
PremiumCompany Announcements
Futura Medical Exceeds 2024 Expectations but Faces Challenges Ahead
PremiumCompany Announcements
Futura Medical Reports Positive Study Results for WSD4000
PremiumCompany Announcements
Futura Medical Reports Positive Outcomes for WSD4000 Study
PremiumCompany Announcements
Futura Medical Issues Shares for Non-Executive Director RemunerationPremiumCompany Announcements
Futura Medical Announces Change in Major Shareholder Voting Rights
PremiumCompany Announcements
Futura Medical’s Major Shareholding Shift
PremiumCompany Announcements
Futura Medical Reveals Promising Product Pipeline Results---
Bulls Say, Bears Say
Bulls Say
Market OpportunityGiven the condition impacts 40-50% of women to some degree, the market opportunity for Futura is significant.
Product DevelopmentFutura has provided a comprehensive update on its new product development pipeline including plans to expand the Eroxon brand and a new potential standalone product focused on female sexual health.
Bears Say
Commercialization ChallengesThe process of obtaining regulatory approval for WSD4000 as the first OTC product to address female sexual dysfunction may pose significant challenges.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.65% Insiders
―
Mutual Funds
― Other Institutional Investors
99.35% Public Companies and
Individual Investors
FUM FAQ
What was Futura Medical PLC’s price range in the past 12 months?
Futura Medical PLC lowest share price was 8.48p and its highest was 45.56p in the past 12 months.
What is Futura Medical PLC’s market cap?
Futura Medical PLC’s market cap is £28.07M.
When is Futura Medical PLC’s upcoming earnings report date?
Futura Medical PLC’s upcoming earnings report date is Apr 09, 2025 which is yesterday.
How were Futura Medical PLC’s earnings last quarter?
Futura Medical PLC released its earnings results on Sep 10, 2024. The company reported 0.003p earnings per share for the quarter, beating the consensus estimate of N/A by 0.003p.
Is Futura Medical PLC overvalued?
According to Wall Street analysts Futura Medical PLC’s price is currently Undervalued.
Does Futura Medical PLC pay dividends?
Futura Medical PLC does not currently pay dividends.
What is Futura Medical PLC’s EPS estimate?
Futura Medical PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Futura Medical PLC have?
Futura Medical PLC has 303,829,680 shares outstanding.
What happened to Futura Medical PLC’s price movement after its last earnings report?
Futura Medical PLC reported an EPS of 0.003p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -5%.
Which hedge fund is a major shareholder of Futura Medical PLC?
Currently, no hedge funds are holding shares in GB:FUM
---
Futura Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
140.00p (1346.28% Upside)
140.00p (1346.28% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-75.41%
12-Months-Change
Fundamentals
Return on Equity
-47.43%
Trailing 12-Months
Asset Growth
-7.26%
Trailing 12-Months
Company Description
Futura Medical PLC
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
---
FUM Stock 12 Month Forecast
Average Price Target
140.00p
▲(1346.28% Upside)
Technical Analysis
Best Analysts Covering FUM
1 Year
1 Year Success Rate
0/6 ratings generated profit
1 Year Average Return
-73.27%
reiterated a buy rating 3 months ago
Copying James Orsborne's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -73.27% per trade.
---